JP2017502946A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017502946A5 JP2017502946A5 JP2016539089A JP2016539089A JP2017502946A5 JP 2017502946 A5 JP2017502946 A5 JP 2017502946A5 JP 2016539089 A JP2016539089 A JP 2016539089A JP 2016539089 A JP2016539089 A JP 2016539089A JP 2017502946 A5 JP2017502946 A5 JP 2017502946A5
- Authority
- JP
- Japan
- Prior art keywords
- radioactive
- formula
- radiotracer
- radiopharmaceutical composition
- content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000700 radioactive tracer Substances 0.000 claims 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 12
- 239000012217 radiopharmaceutical Substances 0.000 claims 11
- 229940121896 radiopharmaceutical Drugs 0.000 claims 11
- 230000002799 radiopharmaceutical effect Effects 0.000 claims 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 10
- 239000000203 mixture Substances 0.000 claims 10
- 238000000034 method Methods 0.000 claims 8
- 101100226004 Rattus norvegicus Erc2 gene Proteins 0.000 claims 6
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims 6
- 230000002285 radioactive effect Effects 0.000 claims 6
- 239000000243 solution Substances 0.000 claims 5
- ZWDVQMVZZYIAHO-COJKEBBMSA-N 2-fluoranylbenzaldehyde Chemical compound [18F]C1=CC=CC=C1C=O ZWDVQMVZZYIAHO-COJKEBBMSA-N 0.000 claims 4
- 239000007864 aqueous solution Substances 0.000 claims 4
- 239000002243 precursor Substances 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 238000001044 reversed-phase solid-phase extraction Methods 0.000 claims 3
- 238000005406 washing Methods 0.000 claims 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims 2
- UOQXIWFBQSVDPP-COJKEBBMSA-N 4-fluoranylbenzaldehyde Chemical compound [18F]C1=CC=C(C=O)C=C1 UOQXIWFBQSVDPP-COJKEBBMSA-N 0.000 claims 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 2
- 239000012156 elution solvent Substances 0.000 claims 2
- KRHYYFGTRYWZRS-BJUDXGSMSA-M fluorine-18(1-) Chemical compound [18F-] KRHYYFGTRYWZRS-BJUDXGSMSA-M 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 239000000718 radiation-protective agent Substances 0.000 claims 2
- 229940124553 radioprotectant Drugs 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 229960004050 aminobenzoic acid Drugs 0.000 claims 1
- 239000012062 aqueous buffer Substances 0.000 claims 1
- 150000001768 cations Chemical class 0.000 claims 1
- 238000007865 diluting Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000002503 metabolic effect Effects 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 claims 1
- 150000003140 primary amides Chemical class 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 230000003537 radioprotector Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1322456.3A GB201322456D0 (en) | 2013-12-18 | 2013-12-18 | Radiotracer compositions and methods |
| GB1322456.3 | 2013-12-18 | ||
| PCT/EP2014/078609 WO2015091882A1 (en) | 2013-12-18 | 2014-12-18 | Radiotracer compositions and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019124883A Division JP2019206533A (ja) | 2013-12-18 | 2019-07-04 | 放射性トレーサー組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017502946A JP2017502946A (ja) | 2017-01-26 |
| JP2017502946A5 true JP2017502946A5 (enExample) | 2017-12-28 |
| JP6824738B2 JP6824738B2 (ja) | 2021-02-03 |
Family
ID=50071052
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016539089A Active JP6824738B2 (ja) | 2013-12-18 | 2014-12-18 | 放射性トレーサー組成物及び方法 |
| JP2019124883A Withdrawn JP2019206533A (ja) | 2013-12-18 | 2019-07-04 | 放射性トレーサー組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019124883A Withdrawn JP2019206533A (ja) | 2013-12-18 | 2019-07-04 | 放射性トレーサー組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US10300156B2 (enExample) |
| EP (1) | EP3082879A1 (enExample) |
| JP (2) | JP6824738B2 (enExample) |
| CN (1) | CN105848687B (enExample) |
| GB (1) | GB201322456D0 (enExample) |
| WO (1) | WO2015091882A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201314936D0 (en) | 2013-08-21 | 2013-10-02 | Ge Healthcare Ltd | Radiolabelling method |
| GB201322456D0 (en) * | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Radiotracer compositions and methods |
| CN108218651B (zh) * | 2018-02-27 | 2023-11-03 | 首都医科大学宣武医院 | 用于制备放射性药物的一次性辅助装置及方法 |
| GB201804835D0 (en) * | 2018-03-26 | 2018-05-09 | Ge Healthcare As | Formulation and method of preparation |
| GB201805253D0 (en) * | 2018-03-29 | 2018-05-16 | Ge Healthcare Ltd Ip | Solid phase extraction |
| GB201915206D0 (en) * | 2019-10-21 | 2019-12-04 | Ge Healthcare Ltd | Use of cyclodextrins as a radiostabilizer |
| GB201919016D0 (en) * | 2019-12-20 | 2020-02-05 | Ge Healthcare Ltd | Apparatus and method for solid phase extraction |
| CA3164293A1 (en) * | 2020-01-10 | 2021-07-15 | Real Isolates, Llc | Methods for obtaining compounds from a plant or fungus material, respective compositions, and uses thereof |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5961955A (en) | 1997-06-03 | 1999-10-05 | Coulter Pharmaceutical, Inc. | Radioprotectant for peptides labeled with radioisotope |
| GB0105224D0 (en) | 2001-03-02 | 2001-04-18 | Nycomed Amersham Plc | Improved peptide-chelate conjugates |
| GB0116815D0 (en) | 2001-07-10 | 2001-08-29 | Nycomed Amersham Plc | Improved chelator conjugates |
| TWI240632B (en) | 2001-07-30 | 2005-10-01 | Epix Medical Inc | Purified peptides for peptide-based multimeric targeted contrast agents |
| JP2005527488A (ja) | 2001-12-27 | 2005-09-15 | バン アンデル リサーチ インスティチュート | Ｍｅｔを発現し、肝細胞増殖因子と結合する腫瘍のモノクローナル抗体画像化および治療 |
| US7018614B2 (en) | 2002-11-05 | 2006-03-28 | Eastern Isotopes, Inc. | Stabilization of radiopharmaceuticals labeled with 18-F |
| AU2002337926B8 (en) * | 2002-11-05 | 2008-02-28 | Ion Beam Applications S.A. | Stabilization of radiopharmaceuticals labeled with 18-F |
| NO20030115D0 (no) | 2003-01-09 | 2003-01-09 | Amersham Health As | Kontrastmiddel |
| CA2517939C (en) | 2003-03-03 | 2015-11-24 | Dyax Corp. | Peptides that specifically bind hgf receptor (cmet) and uses thereof |
| GB0305704D0 (en) | 2003-03-13 | 2003-04-16 | Amersham Plc | Radiofluorination methods |
| GB0420344D0 (en) | 2004-09-14 | 2004-10-13 | Amersham Plc | Diagnostic compounds |
| JP5317475B2 (ja) | 2005-10-24 | 2013-10-16 | 富士フイルムＲｉファーマ株式会社 | 肝細胞増殖因子受容体が関与する疾患の診断薬及び治療薬 |
| EP2043672A4 (en) | 2006-07-07 | 2009-10-21 | Univ Leland Stanford Junior | SELECTIVE INHIBITORS OF CASPASES |
| GB0615211D0 (en) | 2006-07-31 | 2006-09-06 | Ge Healthcare Uk Ltd | Asymmetric flouro-substituted polymethine dyes |
| EP3056509A1 (en) | 2006-09-08 | 2016-08-17 | Piramal Imaging SA | Bombesin analogues for use in diagnosis |
| US7902332B2 (en) | 2006-11-30 | 2011-03-08 | General Electric Company | Fluorine-labeled compounds |
| US8247534B2 (en) | 2006-12-13 | 2012-08-21 | Ge Healthcare As | Synthesis of radiofluorinated peptide using microwave activation technology |
| MX2009009291A (es) | 2007-03-01 | 2009-12-14 | Bayer Schering Pharma Ag | Compuestos activos biologicamente marcados con fluoro-benzoilo 18f como agentes de diagnostico por imagenes asi como precursores de benzotriazol-1-iloxi-benzoilo, 2,5-dioxo-pirrolidin-1-iloxi benzoilo y trimetilamonio benzoilo. |
| BRPI0811210B1 (pt) | 2007-05-16 | 2021-11-09 | Ge Healthcare As | Agente de formação de imagem, composição farmacêutica, método de preparação de um agente de formação de imagem, e, kit para a preparação da composição farmacêutica |
| GB0718957D0 (en) | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Optical imaging agents |
| GB0718967D0 (en) | 2007-09-28 | 2007-11-07 | Ge Healthcare Ltd | Peptide imaging agents |
| GB0716897D0 (en) | 2007-08-30 | 2007-10-10 | Univ Muenchen Tech | Cancer imaging and treatment |
| US20090274623A1 (en) | 2008-01-30 | 2009-11-05 | General Electric Company | In vivo imaging agents for met receptor tyrosine kinase |
| GB0803477D0 (en) | 2008-02-26 | 2008-04-02 | Ge Healthcare As | Therapy selection method |
| EP2268609B1 (en) * | 2008-02-28 | 2013-01-30 | GE Healthcare Limited | Synthesis of a PEG-6 moiety from commercial low-cost chemicals |
| US8435454B2 (en) * | 2009-07-09 | 2013-05-07 | Siemens Medical Solutions Usa, Inc. | Modular system for radiosynthesis with multi-run capabilities and reduced risk of radiation exposure |
| EP2454598B1 (en) | 2009-07-15 | 2017-03-22 | DiaTech Holdings, Inc. | Drug selection for gastric cancer therapy using antibody-based arrays |
| EP2287197A1 (en) | 2009-08-21 | 2011-02-23 | Pierre Fabre Medicament | Anti-cMET antibody and its use for the detection and the diagnosis of cancer |
| GB0918321D0 (en) | 2009-10-20 | 2009-12-02 | Ge Healthcare As | Cyclic peptide synthesis |
| GB201013808D0 (en) | 2010-08-18 | 2010-09-29 | Ge Healthcare Ltd | Peptide radiotracer compositions |
| EP3395373B1 (en) | 2010-12-01 | 2022-10-19 | GE Healthcare Limited | Method for labelling a biological targeting molecule via conjugation with a radioisotope suitable for pet or spect imaging |
| GB201020314D0 (en) | 2010-12-01 | 2011-01-12 | Ge Healthcare Ltd | Apoptosis pet imaging agents |
| EP2648767B1 (en) | 2010-12-09 | 2023-03-15 | GE Healthcare Limited | Radiotracer compositions |
| ES2739504T3 (es) | 2010-12-21 | 2020-01-31 | Ge Healthcare Ltd | Uso de anilina en la radioestabilización de una ligadura de oxima |
| US20130295010A1 (en) | 2010-12-22 | 2013-11-07 | Duncan Hiscock | Her2 binding peptides labelled with a 18f - containing organosilicon compound |
| GB201103696D0 (en) | 2011-03-04 | 2011-04-20 | Ge Healthcare Ltd | Technetium labelled peptides |
| GB201121914D0 (en) | 2011-12-20 | 2012-02-01 | Ge Healthcare Ltd | Method for patient selection |
| GB201202420D0 (en) * | 2012-02-13 | 2012-03-28 | Ge Healthcare Ltd | Radiotracer compositions |
| GB201209082D0 (en) | 2012-05-24 | 2012-07-04 | Ge Healthcare Ltd | Purification method |
| GB201314936D0 (en) | 2013-08-21 | 2013-10-02 | Ge Healthcare Ltd | Radiolabelling method |
| GB201322456D0 (en) * | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Radiotracer compositions and methods |
| GB201322451D0 (en) | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Purification method and compositions |
-
2013
- 2013-12-18 GB GBGB1322456.3A patent/GB201322456D0/en not_active Ceased
-
2014
- 2014-12-18 EP EP14814895.0A patent/EP3082879A1/en active Pending
- 2014-12-18 WO PCT/EP2014/078609 patent/WO2015091882A1/en not_active Ceased
- 2014-12-18 US US15/102,952 patent/US10300156B2/en active Active
- 2014-12-18 CN CN201480069324.9A patent/CN105848687B/zh active Active
- 2014-12-18 JP JP2016539089A patent/JP6824738B2/ja active Active
-
2019
- 2019-04-04 US US16/375,223 patent/US11311636B2/en active Active
- 2019-07-04 JP JP2019124883A patent/JP2019206533A/ja not_active Withdrawn
-
2022
- 2022-03-15 US US17/695,810 patent/US20220202965A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017502946A5 (enExample) | ||
| CN102712603B (zh) | 放射性碘标记方法 | |
| JP2022136074A (ja) | 新規製剤及び合成方法 | |
| CA2807491A1 (en) | F18 c-met binding cyclic peptide radiotracers and compositions thereof | |
| CN103889930B (zh) | 用于制备68Ga络合物的工艺 | |
| JP6968809B2 (ja) | ジアリールヨードニウム塩を使用してヨード−又はアスタトアレーンを合成するための方法 | |
| KR20110006658A (ko) | 직접적인 친핵성 절차를 위한 정제 전략 | |
| KR102109225B1 (ko) | 18f-플루시클로빈의 제조 | |
| Craig et al. | Preparation of labeled aromatic amino acids via late-stage 18 F-fluorination of chiral nickel and copper complexes | |
| Haveman et al. | State of the art procedures towards reactive [18F] fluoride in PET tracer synthesis | |
| ES2654528T3 (es) | Procedimiento de preparación de un derivado de purina marcado, dicho derivado y sus usos | |
| US8629299B2 (en) | Radiofluorinated compounds and their preparation | |
| ES2892034T3 (es) | Proceso para la purificación de Ga-68 a partir del eluato derivado de generadores de 68Ge/ 68Ga | |
| US20100228060A1 (en) | Perfluoro-aryliodonium salts in nucleophilic aromatic 18f-fluorination | |
| WO2022189304A2 (en) | Aliphatic 18f-radiolabeling of a tetrazine precursor | |
| Wang et al. | Synthesis and biological evaluation of 18F labeled fluoro-oligo-ethoxylated 4-benzylpiperazine derivatives for sigma-1 receptor imaging | |
| FR2949113A1 (fr) | Composes a base de sultones, leurs derives substitues par des nucleophiles, notamment des radionucleides, procedes et applications | |
| JP2017501152A5 (enExample) | ||
| JP2015516457A (ja) | 放射性医薬品の製造用キット及び製造方法 | |
| WO2018233798A1 (en) | Novel psma-binding agents and uses thereof | |
| JP2013515036A (ja) | 放射性ヨウ素化トロパン誘導体 | |
| KR102084472B1 (ko) | 다양한 압타머에 적용 가능한 방사성동위원소 표지된 핵산 구조체 개발 및 표지방법 | |
| Chiotellis et al. | Synthesis, characterization and biological evaluation of novel neutral fac-M (CO) 3 (SNO) complexes (M= Re, 99mTc) bearing the o-methoxyphenylpiperazine moiety | |
| WO2012105814A2 (ko) | 개선된 플루오르-18 표지를 위한 트리아자노난 유도체 또는 이의 약학적으로 허용가능한 염 | |
| US20160022845A1 (en) | Synthon composition |